Abstract
Opioid peptides and their G protein-coupled receptors (GPCRs) are important regulators within the cardiovascular system, implicated in modulation of electrophysiological function, heart rate, myocardial inotropy, vascular function, and cellular stress resistance. The opioid system is also involved in cardiovascular development, adaptation to injury and effects of advanced age. The significant roles of opioids are emphasized by the observation that the heart produces prodynorphin and proenkephalin, which are enzymatically processed from small to large active polypeptides. Indeed, depending on species, cardiac preproenkephalin mRNA levels are comparable to or higher than those found in the central nervous system. This review highlights and discusses current knowledge and recent findings regarding physiological and pathophysiological modulation of the heart and vessels by the opioid receptor system.
Keywords: Opioid peptide, opioid receptor, cardiovascular system, cytoprotection, G protein-coupled receptors (GPCRs), electrophysiological function, heart rate, myocardial inotropy, vascular function, cellular stress resistance.
Current Pharmaceutical Design
Title:Non-Analgesic Effects of Opioids: Cardiovascular Effects of Opioids and their Receptor Systems
Volume: 18 Issue: 37
Author(s): John P. Headrick, Salvatore Pepe and Jason N. Peart
Affiliation:
Keywords: Opioid peptide, opioid receptor, cardiovascular system, cytoprotection, G protein-coupled receptors (GPCRs), electrophysiological function, heart rate, myocardial inotropy, vascular function, cellular stress resistance.
Abstract: Opioid peptides and their G protein-coupled receptors (GPCRs) are important regulators within the cardiovascular system, implicated in modulation of electrophysiological function, heart rate, myocardial inotropy, vascular function, and cellular stress resistance. The opioid system is also involved in cardiovascular development, adaptation to injury and effects of advanced age. The significant roles of opioids are emphasized by the observation that the heart produces prodynorphin and proenkephalin, which are enzymatically processed from small to large active polypeptides. Indeed, depending on species, cardiac preproenkephalin mRNA levels are comparable to or higher than those found in the central nervous system. This review highlights and discusses current knowledge and recent findings regarding physiological and pathophysiological modulation of the heart and vessels by the opioid receptor system.
Export Options
About this article
Cite this article as:
P. Headrick John, Pepe Salvatore and N. Peart Jason, Non-Analgesic Effects of Opioids: Cardiovascular Effects of Opioids and their Receptor Systems, Current Pharmaceutical Design 2012; 18 (37) . https://dx.doi.org/10.2174/138161212803582360
DOI https://dx.doi.org/10.2174/138161212803582360 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Ultrasound Techniques for Drug Delivery in Cardiovascular Medicine
Current Drug Discovery Technologies Luteolin Antagonizes Angiotensin II-Dependent Proliferation and Collagen Synthesis of Cultured rat Cardiac Fibroblasts
Current Pharmaceutical Biotechnology Peripheral Blood Derived Cell Trafficking for Cardiac Regeneration
Current Stem Cell Research & Therapy Demystifying the ACE Polymorphism: From Genetics to Biology
Current Pharmaceutical Design The Therapeutic Potential of Bone Marrow Mesenchymal Stem Cells for Articular Cartilage Regeneration in Osteoarthritis
Current Stem Cell Research & Therapy Patent Selections:
Recent Patents on Drug Delivery & Formulation Neuroimmune Activation in Chronic Heart Failure
Endocrine, Metabolic & Immune Disorders - Drug Targets The Fetal Cardiac Function
Current Cardiology Reviews Basal Septal Hypertrophy
Current Cardiology Reviews Pharmaceutical Measures to Prevent Doxorubicin-Induced Cardiotoxicity
Mini-Reviews in Medicinal Chemistry Insights into the Relationship Between Hypertension and Albuminuria
Current Hypertension Reviews Novel Strategies for the Management of Acute Decompensated Heart Failure
Current Cardiology Reviews NTproBNP: An Important Biomarker in Cardiac Diseases
Current Topics in Medicinal Chemistry Genomic and Non-genomic Effects of Aldosterone
Current Signal Transduction Therapy Cell Penetrating Peptide Delivery of Splice Directing Oligonucleotides as a Treatment for Duchenne Muscular Dystrophy
Current Pharmaceutical Design Usefulness of 5 Minutes <sup>123</sup>I-mIBG Scan in Parkinson’s Disease and Heart Failure
Current Radiopharmaceuticals Meet the Editorial Board
Current Drug Targets Myocardial Energy Substrate Metabolism in Heart Failure : from Pathways to Therapeutic Targets
Current Pharmaceutical Design Medicinal Plants and Bioactive Compounds for Diabetes Management: Important Advances in Drug Discovery
Current Pharmaceutical Design Current Use of Cardiac Biomarkers in Various Heart Conditions
Endocrine, Metabolic & Immune Disorders - Drug Targets